COVID-19 vaccines in multiple sclerosis treated with cladribine or ocrelizumab

Publication date: Available online 4 May 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Fabio Buttari, Antonio Bruno, Ettore Dolcetti, Federica Azzolini, Paolo Bellantonio, Diego Centonze, Roberta Fantozzi

Source: Multiple Sclerosis and Related Disorders - May 4, 2021 Category: Neurology Source Type: research